Greenblatt Rb

The efficacy of therapeutic doses of Provest (10 mg medroxyprogesterone acetate .05 mg ethinyl estradiol) in controlling adolescent menstrual disorders was evaluated in 19 girls. Treatment for 3-6 months satisfactorily prevented amenorrhea-…

Danazol, an interesting pharmacologic steroid 'in search of a disease', was first used by my group in the management of endometriosis because of the marked anti-endometrial effects found during clinical trials. The results in alleviating dy…

Forty-nine women diagnosed as having pelvic endometriosis were treated with 800 mg of danazol/day for a mean duration of 6 months. The average length of the follow-up period was 78 months. Side effects were minimal, and regular ovulatory me…

One hundred thirty-five women with benign breast disease (BBD) were treated with danazol, an impeded androgen. Their ages ranged from 19 to 60 years (mean age, 30). The dose varied from 100 to 800 mg per day for 90 to 180 days, depending up…

The contraceptive properties of Danazol a steroid derivative of eth isterone were investigated in 30 volunteers. The drug was administered for 90 days in daily doses of either 50 100 or 200 mg. There were no pregnancies. Consistent inhibiti…

Danazol (2-3-isoxazol-17alpha-ethinyl-testosterone) was prescribed to 42 normally cycling women some endometriosis patients some primary and secondary infertility patients 6 girls with precocious puberty several women with breast disorders …

The past present and future of the oral contraceptive pill is summarized broadly including ancient history and efficacy of traditional contraceptives and use of early estrogen treatment for dysmennorhea (1940-1952). The present development …